Reticulate erythema associated with violaceous papules on the forearms
Sara Zafar
Department of Dermatology
Visiting Clinicians at the Department of Dermatology.
Search for more papers by this authorFarzaneh Khezri MD
Department of Dermatology
Visiting Clinicians at the Department of Dermatology.
Search for more papers by this authorLawrence E. Gibson MD
Department of Dermatology
Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA
Search for more papers by this authorNneka I. Comfere MD
Department of Dermatology
Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA
Search for more papers by this authorSara Zafar
Department of Dermatology
Visiting Clinicians at the Department of Dermatology.
Search for more papers by this authorFarzaneh Khezri MD
Department of Dermatology
Visiting Clinicians at the Department of Dermatology.
Search for more papers by this authorLawrence E. Gibson MD
Department of Dermatology
Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA
Search for more papers by this authorNneka I. Comfere MD
Department of Dermatology
Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA
Search for more papers by this authorAbstract
What is your diagnosis?
References
- 1Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis2007; 66: 222–227. Epub 2006 Aug 10.
- 2Hogan SL, Falk RJ, Chin H, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med2005; 143: 621–631.
- 3Keogh KA, Specks U. Churg-Strauss syndrome. Semin Respir Crit Care Med2006; 27: 148–157.
- 4Hoffman GS, Langford CA. Are there different forms of life in the antineutrophil cytoplasmic antibody universe? [Editorial.]. Ann Intern Med2005; 143: 683–685.
- 5Barksdale SK, Hallahan CW, Kerr GS, et al. Cutaneous pathology in Wegener’s granulomatosis: a clinicopathologic study of 75 biopsies in 46 patients. Am J Surg Pathol1995; 19: 161–172.
- 6Hu CH, O’Loughlin S, Winkelmann RK. Cutaneous manifestations of Wegener granulomatosis. Arch Dermatol1977; 113: 175–182.
- 7Fiorentino DF. Cutaneous vasculitis. J Am Acad Dermatol2003; 48: 311–340.
- 8Comfere NI, Macaron NC, Gibson LE. Cutaneous manifestations of Wegener’s granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status. J Cutan Pathol2007; 34: 739–747.
- 9Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum1994; 37: 187–192.
- 10Savige J, Pollock W, Trevisin M. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?Best Pract Res Clin Rheumatol2005; 19: 263–276.
- 11Addis BJ. Wegener’s granulomatosis, ANCA, and microscopic polyarteritis. J Pathol1991; 164: 189–190.
- 12Nakamura T, Kanazawa N, Ikeda T, et al. Cutaneous polyarteritis nodosa: revisiting its definition and diagnostic criteria. Arch Dermatol Res2009; 301: 117–121. Epub 2008 Sep 19.
- 13Kuchel J, Lee S. Cutaneous Wegener’s granulomatosis: a variant or atypical localized form?Australas J Dermatol2003; 44: 129–135.
- 14Morgan AJ, Schwartz RA. Cutaneous polyarteritis nodosa: a comprehensive review. Int J Dermatol2010; 49: 750–756.
Citing Literature
